How to cite item

How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: an international multidisciplinary team

   
@article{JTD22209,
	author = {Yalei Zhang and Jianfei Shen and Charles B. Simone II and Federico Cappuzzo and Kwun M. Fong and Rafael Rosell and Joe Y. Chang and Luca Ampollini and J. Isabelle Choi and Jianxing He and Tao Jiang and Written on behalf of AME Lung Cancer Cooperative Group},
	title = {How to optimize the treatment strategy for patients with  EGFR-mutant stage IA lung adenocarcinoma: an international  multidisciplinary team},
	journal = {Journal of Thoracic Disease},
	volume = {10},
	number = {6},
	year = {2018},
	keywords = {},
	abstract = {Although most patients with stage I non-small cell lung cancer (NSCLC) can achieve long-term survival, some still remain at high risk of relapse (1-3). The excellent outcomes and increasing use of stereotactic ablative radiotherapy (SABR) for stage I NSCLC has recently posed a challenge to surgery (4,5). Nevertheless, lobectomy with mediastinal lymph node dissection or sampling has remained the standard of care for operable, stage I NSCLC.},
	issn = {2077-6624},	url = {https://jtd.amegroups.org/article/view/22209}
}